A
Ajay
About Ajay
Data last updated:
Ajay is a Director at Grapple Lifesciences Private Limited (since 2023), Director at Ampira Biotechnics Private Limited (since 2019) and Director at Medlex Biotechnics Private Limited (since 2020), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹19.44 Cr; the largest is Grapple Lifesciences Private Limited at ₹8.93 Cr (FY 2025). Earlier, Ajay was a Director at N.N Remedies Private Limited (2018–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Dec 2023 | 2011 | ₹8.93 Cr (FY 2025) | Active | |
| Director | 12 Feb 2019 | 2019 | ₹7.07 Cr (FY 2024) | Active | |
| Director | 16 Dec 2020 | 2020 | ₹3.20 Cr (FY 2024) | Active | |
| Director | 25 Nov 2020 | 2020 | ₹23.6 Lakh (FY 2024) | Active | |
| Director | 16 Dec 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Apr 2018 | 2018 | ₹2.25 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ajay
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satwant Singh | 06420859 | Grapple Lifesciences Private Limited , Ampira Biotechnics Private Limited and 3 more | Director |
| Babita | 08359360 | Ampira Biotechnics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajay
Ajay currently holds 5 directorships: Grapple Lifesciences Private Limited (Director, since 28 Dec 2023, revenue ₹8.93 Cr (FY 2025)); Ampira Biotechnics Private Limited (Director, since 12 Feb 2019, revenue ₹7.07 Cr (FY 2024)); Medlex Biotechnics Private Limited (Director, since 16 Dec 2020, revenue ₹3.20 Cr (FY 2024)); Livin Herbal Private Limited (Director, since 25 Nov 2020, revenue ₹23.6 Lakh (FY 2024)); Qantas Labs Private Limited (Director, since 16 Dec 2020).
Ajay was first appointed on 11 Apr 2018 as Director at N.N Remedies Private Limited. The most recent appointment on record is 28 Dec 2023 at Grapple Lifesciences Private Limited.
The 4 current companies of Ajay that report revenue have a combined latest revenue of ₹19.44 Cr: Grapple Lifesciences Private Limited ₹8.93 Cr (FY 2025); Ampira Biotechnics Private Limited ₹7.07 Cr (FY 2024); Medlex Biotechnics Private Limited ₹3.20 Cr (FY 2024); Livin Herbal Private Limited ₹23.6 Lakh (FY 2024).
Ajay held 1 earlier board appointment: N.N Remedies Private Limited (Director, 11 Apr 2018 to 29 Dec 2023).
The current boards of Ajay's companies include Satwant Singh (Grapple Lifesciences Private Limited), Babita (Ampira Biotechnics Private Limited).